Nebulized Epinephrine vs. Salbutamol in Bronchiolitis Among Children
Status:
Recruiting
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
Acute bronchiolitis, mostly secondary to infection due to Respiratory syncytial virus (RSV)
is very common in infants under two years old. It is usually benign. However, the dyspnea it
causes is a big concern for parents and this disease can take a severe form on certain
particular ground thus constituting a frequent reason for hospitalization in pediatrics.
Nebulized epinephrine showed more efficacy than nebulized salbutamol.